Glutethimide Industry Insights to Reach USD 446.09 Million by 2032
Glutethimide is a sedative-hypnotic drug primarily used to treat insomnia by inducing drowsiness and calming effects. It is a lipophilic compound that concentrates in adipose tissue and the brain. As a Schedule II controlled substance, it is known for its ability to induce the conversion of codeine into morphine when combined with it. Glutethimide is metabolized in the liver and its metabolites...
0 Comentários 0 Compartilhamentos